Injective (INJ) is currently priced at $2.77, reflecting a 5.47% decline over the past 24 hours. The daily price range has been narrow, fluctuating between a low of $2.76 and a high of $2.95, indicating limited volatility amidst bearish sentiment.

Trading volume over the last 24 hours stands at approximately 42.55 million, representing 15.31% of the market cap, which suggests active trading but may also reflect a lack of strong buying pressure. The hourly moving averages indicate a downtrend, with the 8 SMA at $2.78 showing a decrease of 0.50% and the 55 SMA at $2.87 down by 3.37%, signaling a bearish short-term trend.

The 1-hour Relative Strength Index (RSI) is critically low at 24, suggesting an oversold condition which typically precedes a potential price rebound. In contrast, the 7-day RSI is at 47, indicating that the asset is nearing neutral territory but still trending downward, supported by a 7-day price change of -6.26%.

Over the past 14 and 30 days, the price has declined by 7.71% and 7.73%, respectively, indicating a consistent downward pressure. Given the significant gap from its all-time high of $52.62 reached in March 2024, current valuations reflect a substantial contraction in investor sentiment and market confidence.

Based on the current technical indicators and the negative price trends over multiple timeframes, Injective (INJ) appears to be under significant bearish pressure with no immediate signs of recovery. Therefore, the recommendation is to Hold at this moment, awaiting potential stabilization or a reversal signal before considering any buy positions.